Cystic Fibrosis Foundation – Accelerating the Discovery of Nonsense Mutation Therapies for CF
9/20/2019
Purpose Successful proposals will focus on strategies, tools, technologies, and model systems that will advance the development of nonsense mutation-directed therapies for CF. Award Types There are two program options:…
Doris Duke Charitable Foundation – Clinical Scientist Development Award
9/20/2019
Purpose The Doris Duke Clinical Scientist Development Award provides grants to junior physician scientists to facilitate their transition to independent clinical research careers. Background The transition to an independent research…
9/20/2019
Purpose This FOA invites applications to provide infrastructure support for advancing the development of high-priority effectiveness research on recovery support services for individuals with opioid use disorder who received or…
9/20/2019
Purpose This funding opportunity announcement (FOA) solicits research projects that seek to model the underlying mechanisms, processes, and trajectories of social relationships and how these factors affect outcomes in health,…
NIH – Trans-Agency Blood-Brain Interface Program (R61/R33 – Clinical Trials Not Allowed)
9/10/2019
Purpose This Funding Opportunity Announcement (FOA) will support high risk/high reward research on the blood/vascular component and regulation of the neurovascular blood unit (aka. Blood-Brain Barrier; BBB) in normal and…
NIH – The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Required)
9/9/2019
Purpose: This Funding Opportunity Announcement (FOA) invites applications from clinical investigators to participate in the National Drug Abuse Treatment Clinical Trials Network (CTN). NIDA intends to continue to develop and test…
NIH – Special Notices in Trauma Care Technology
9/9/2019
Purpose: NIBIB has published four Notices of Special Interest in the field of trauma care with the goal of enabling the development of marketable products within the next 5-10 years.…
9/4/2019
Purpose: The purpose of this FOA is to support a Multisite Clinical Center to implement the enrollment and multimodal longitudinal assessment of a large cohort of patients that EITHER experienced…
National Cancer Institute – Research Specialist Award
9/4/2019
Purpose: The National Cancer Institute is pleased to announce the reissuance of the Research Specialist Award (R50), a workforce development initiative. These funding opportunity announcements (FOAs) are targeted to non-tenure…
Melanoma Research Alliance – General RFP
9/4/2019
Purpose: The Melanoma Research Alliance (MRA) announces a Request for Proposals (RFP) soliciting high-impact pre-clinical, translational, and early clinical research from scientists and clinicians around the world. The RFP calls…